Atea Pharmaceuticals (AVIR) Tax Provisions: 2021-2024
Historic Tax Provisions for Atea Pharmaceuticals (AVIR) over the last 4 years, with Dec 2024 value amounting to $925,000.
- Atea Pharmaceuticals' Tax Provisions fell 97.00% to $123,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $510,000, marking a year-over-year change of. This contributed to the annual value of $925,000 for FY2024, which is 9.14% down from last year.
- Per Atea Pharmaceuticals' latest filing, its Tax Provisions stood at $925,000 for FY2024, which was down 9.14% from $1.0 million recorded in FY2023.
- Over the past 5 years, Atea Pharmaceuticals' Tax Provisions peaked at $17.4 million during FY2021, and registered a low of -$3.6 million during FY2022.
- Moreover, its 3-year median value for Tax Provisions was $925,000 (2024), whereas its average is -$549,000.
- Per our database at Business Quant, Atea Pharmaceuticals' Tax Provisions plummeted by 120.63% in 2022 and then spiked by 128.36% in 2023.
- Yearly analysis of 4 years shows Atea Pharmaceuticals' Tax Provisions stood at $17.4 million in 2021, then crashed by 120.63% to -$3.6 million in 2022, then surged by 128.36% to $1.0 million in 2023, then fell by 9.14% to $925,000 in 2024.